Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04790656
Other study ID # REC/00874 Arjumand Bano
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 14, 2020
Est. completion date August 20, 2021

Study information

Verified date September 2021
Source Riphah International University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim is to evaluate the effectiveness of physical exercise on a cycle ergometer combine with CPAP in the postoperative period after myocardial revascularization


Description:

Physical exercise on a cycle ergometer combine with CPAP as an adjunct to the rehabilitation of hospitalized subjects who will undergo myocardial revascularization will be safe, decrease the length of stay in the ICU, and help maintain functional capacity


Recruitment information / eligibility

Status Completed
Enrollment 102
Est. completion date August 20, 2021
Est. primary completion date August 20, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years to 75 Years
Eligibility Inclusion Criteria: - Subjects who have undergone myocardial revascularization surgery - An ejection fraction of greater than40% - Post operative mechanical ventilation for <12hours - No definite diagnosis of chronic obstructive pulmonary disease and asthma Exclusion Criteria: - With complications in post operative period (e.g., Artial fibrillation, prolonged mechanical ventilation) - Hemodynamically unstable patients - Intolerance to CPAP(continuous positive airway)mask

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Conventional Therapy
Subjects will randomly placed into intervention group and control group . In addition to the physiotherapeutic program standardized by the hospital's team of physical therapists, the intervention group will perform physical exercise on a cycle ergometer with CPAP.
Cycle ergometer combine with CPAP
Physical exercise on a cycle ergometer combine with CPAP will be performed in a single daily session from the second to the fourth postoperative days . The maximum exercise time for postoperative day 2 will be 20 min, and 30 min for the third and fourth postoperative days.

Locations

Country Name City State
Pakistan Rawalpindi institute of cardiology Rawalpindi Punjab

Sponsors (1)

Lead Sponsor Collaborator
Riphah International University

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Modified Borg scale The Modified Borg Dyspnoea Scale is most commonly used to assess symptoms of breathlessness. Despite being a subjective measure of exercise intensity, RPE scales provide valuable information when used correctly. 4th day
Primary 6 min walk distance The six minute walking test (6MWT) was developed by the American Thoracic Society and it was officially introduced in 2002, coming along with a comprehensive guideline. The 6 Minute Walk Test is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity 4th day
Primary 1 min sit to stand test Vaidya et al reported that 1-minute STS test is a simple and sensitive test and appears to be a practical, reliable, valid, and responsive alternative for measuring exercise capacity, particularly where space and time are limited 4th day
Primary Digital Monovacumeter The manovacuometer is a simple, quick and non-invasive test which measures the maximal respiratory pressures (MRS).Digital manovacuometer is a reliable and valid instrument for assessing maximum inspiratory pressure and maximum expiratory pressure in healthy subjects 4th day
See also
  Status Clinical Trial Phase
Completed NCT02840006 - Spinal Anesthesia Associated With General Anesthesia in Coronary Artery Bypass Phase 4
Completed NCT05466825 - Global Cardiovascular Risk Consortium
Recruiting NCT04591938 - FANTOM ENCORE Sirolimus-eluting Bioresorbable Scaffold for Treatment of De-novo CAD: the ENCORE-I Study N/A
Completed NCT01841944 - Omega-3 Fatty Acids in Elderly Patients With Acute Myocardial Infarction N/A
Recruiting NCT03562572 - FFR Driven Complete Revascularization Versus Usual Care in NSTEMI Patients and Multivessel Disease N/A
Recruiting NCT00755248 - Coronary Artery Bypass Grafting: Factors Related to Late Events and Saphenous Graft Patency N/A
Not yet recruiting NCT00388245 - Revascularization in Heart Failure Trial – REHEAT 2 Phase 4
Completed NCT00375063 - Study of Unprotected Left Main Stenting Versus Bypass Surgery (LE MANS Study) Phase 4
Completed NCT02580851 - Magnetic Resonance Adenosine Perfusion Imaging as Gatekeeper of Invasive Coronary Intervention N/A
Recruiting NCT04683133 - The FAST OCT Study N/A
Withdrawn NCT00463853 - Stem Cell Therapy as Adjunct to Revascularization Phase 1
Completed NCT00157716 - MEND-CABG (MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery) Phase 2